CIK 0001178670
- Large accelerated filer
ALNYLAM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ALNY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770602661
- Phone
- +1 617-551-8200
- Business address
- 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
- Former names
- ALNYLAM PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $543,126
- in 2 filings
- Open-market sales, last 90 days
- $398,855
- in 1 filing
Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-19 | KEATING LAURIE EVP, Chief Legal Officer | Grant or award | +4,518 | 8,955 | ||
| 2021-04-19 | MARAGANORE JOHN Chief Executive Officer | Grant or award | +16,236 | 222,272 | ||
| 2021-02-25 | MARAGANORE JOHN Chief Executive Officer | Exercise or conversion | +33,979 | $7.10 | $241K | 240,015 |
| 2021-02-25 | MARAGANORE JOHN Chief Executive Officer | Sale | −1,001 | $143.88 | $144K | 239,014 |
| 2021-02-25 | MARAGANORE JOHN Chief Executive Officer | Sale | −6,129 | $145.15 | $890K | 232,885 |
| 2021-02-25 | MARAGANORE JOHN Chief Executive Officer | Sale | −9,376 | $146.13 | $1.4M | 223,509 |
| 2021-02-25 | MARAGANORE JOHN Chief Executive Officer | Sale | −6,097 | $146.98 | $896K | 217,412 |
| 2021-02-25 | MARAGANORE JOHN Chief Executive Officer | Sale | −4,375 | $148.00 | $648K | 213,037 |
| 2021-02-25 | MARAGANORE JOHN Chief Executive Officer | Sale | −1,364 | $148.96 | $203K | 211,673 |
| 2021-02-25 | MARAGANORE JOHN Chief Executive Officer | Sale | −2,054 | $150.22 | $309K | 209,619 |
| 2021-02-25 | MARAGANORE JOHN Chief Executive Officer | Sale | −1,415 | $151.31 | $214K | 208,204 |
| 2021-02-25 | MARAGANORE JOHN Chief Executive Officer | Sale | −1,138 | $152.46 | $173K | 207,066 |
| 2021-02-25 | MARAGANORE JOHN Chief Executive Officer | Sale | −431 | $153.33 | $66K | 206,635 |
| 2021-02-25 | MARAGANORE JOHN Chief Executive Officer | Sale | −599 | $154.59 | $93K | 206,036 |
| 2021-02-25 | MARAGANORE JOHN Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −33,979 | 101,936 | ||
| 2021-02-24 | Vaishnaw Akshay President, R&D | Grant or award · Stock Option (right to buy) | +28,800 | 28,800 | ||
| 2021-02-24 | Greenstreet Yvonne President & COO | Grant or award · Stock Option (right to buy) | +28,800 | 28,800 | ||
| 2021-02-24 | KEATING LAURIE EVP, Chief Legal Officer | Grant or award · Stock Option (right to buy) | +17,846 | 17,846 | ||
| 2021-02-24 | Poulton Jeffrey V. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +23,200 | 23,200 | ||
| 2021-02-24 | MARAGANORE JOHN Chief Executive Officer | Grant or award · Stock Option (right to buy) | +79,998 | 79,998 |
Page 70 of 80 · 1,590 trades